← Evidence map

ReviewDrugs2017

Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma.

Lesley J ScottPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

63 papers cite itlatest 60 shown

2017
…
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28190142